We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bladder Tests in Women Before Urinary Incontinence Surgery Unnecessary

By HospiMedica International staff writers
Posted on 30 May 2012
An invasive and costly test commonly performed in women before surgery for stress urinary incontinence was shown to be unnecessary.

A study funded by the US National Institutes of Health (Bethesda, MD, USA) compared results after both a preoperative check-up in a doctor’s office and bladder function tests to results after only the office check-up. More...
Women who had only the office check-up had equally successful outcomes after surgery.

Moreover, called urodynamic studies, bladder function tests help assess how well the bladder, sphincter muscles, and urethra store and release urine. The insertion of catheters and filling the bladder until full as required by some of the tests can be very uncomfortable or even painful for many women. The average cost is approximately USD 500.

In the study, half of 630 women with uncomplicated stress urinary incontinence had a preoperative office check-up and bladder function testing. The other half had only an office check-up. Treatment success was similar in both groups, 76.9% versus 77.2%, respectively, with no significant differences in quality of life, patient satisfaction, or voiding dysfunction, the inability to empty the bladder completely.

“Bladder function tests are often performed before surgery in women who demonstrate stress incontinence upon office evaluation,” said study lead author Charles Nager, MD, director of urogynecology and reconstructive pelvic surgery at the University of California, San Diego, USA. “The findings of our study argue against routine preoperative testing in cases of uncomplicated stress urinary incontinence, as the tests provide no added benefit for surgical treatment success but are expensive, uncomfortable, and may result in complications such as urinary tract infections.”

Results of the study, performed by the Urinary Incontinence Treatment Network (UITN), are posted on the New England Journal of Medicine (NEJM) website (please see Related Links below) and published in the journal's print issue. The UITN is a group of urologists and urogynecologists from all over the country who are conducting research on the treatment of urinary incontinence, or accidental loss of urine.

Related Links:

Urinary Incontinence Treatment Network
National Institute of Diabetes and Digestive and Kidney Diseases
NEJM



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.